| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910153561403321 |
|
|
Titolo |
Facets of Facebook : use and users / / edited by Kathrin Knautz and Katsiaryna S. Baran |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Berlin ; ; Boston : , : De Gruyter Saur, , 2016 |
|
|
|
|
|
|
|
ISBN |
|
3-11-041816-9 |
3-11-041820-7 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (x, 328 pages) |
|
|
|
|
|
|
Collana |
|
Knowledge and information |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Online social networks |
Internet users |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Frontmatter -- Preface / Baran, Katsiaryna S. / Knautz, Kathrin -- Contents -- Chapter 1. Unfriending and Becoming Unfriended on Facebook / Gashi, Liridona / Knautz, Kathrin -- Chapter 2. Photo Publication Behavior of Adolescents on Facebook / Dorsch, Isabelle / Ilhan, Aylin -- Chapter 3. Does Facebook Cause Addiction? An Analysis of German Facebook Users / Hartmann, Sarah / Wanner, Brigitta -- Chapter 4. Facebook Social Games / Kinder-Kurlanda, Katharina / Willson, Michele -- Chapter 5. Information Literacy Levels of Facebook Users / Ciftci, Tuba / Knautz, Kathrin -- Chapter 6. Privacy in Social Networks After the Global Surveillance Disclosures / Wittig, Kai -- Chapter 7. From Cooperation to Compassion: Death and Bereavement on Social Networking Websites / Veszelszki, Ágnes / Parapatics, Andrea -- Chapter 8. Facebook: A Source for Microhistory? / Stock, Mechtild -- Chapter 9. Social Media as Channels for the Public Communication of Science: The Case of Spanish Research Centers and Public Universities / López-Pérez, Lourdes / Olvera-Lobo, María Dolores -- Chapter 10. "Blind as a Bat": Users of Social Networking Services and Their Biased Quality Estimations in TAM-like Surveys / Baran, Katsiaryna S. / Stock, Wolfgang G. -- Chapter 11. New Media and New Territories for European Law: Competition in the Market for Social Networking Services / Fietkiewicz, Kaja J. / Lins, Elmar -- Index |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This collected volume gathers a broad spectrum of social science and information science articles about Facebook. It looks into facets of users, such as age, sex, and culture, and into facets of use, e.g. privacy behavior after the Snowden affair, unfriending on Facebook, or Facebook addiction, as well as into quality perceptions. Written by leading scholars investigating the impact of Web 2.0., this volume is highly relevant for social media researchers, information scientists, and social scientists, and, not least, for everyone interested in Facebook-related topics. |
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910972032203321 |
|
|
Autore |
Nikanorova Marina |
|
|
Titolo |
Orphan Drugs in Epilepsy |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Montrouge, : JOHN LIBBEY EUROTEXT, 2014 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (90 p.) |
|
|
|
|
|
|
Collana |
|
Topics in Epilepsy ; ; v.4 |
|
|
|
|
|
|
Altri autori (Persone) |
|
JohannessenS. I |
GentonPierre |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Epilepsy -- Treatment |
Brain Diseases |
Central Nervous System Agents |
Drug Industry |
Industry |
Therapeutic Uses |
Central Nervous System Diseases |
Nervous System Diseases |
Technology, Industry, and Agriculture |
Pharmacologic Actions |
Chemical Actions and Uses |
Disease |
Anticonvulsants |
Epilepsy |
Orphan Drug Production |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
|
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
""Orphan Drugs in Epilepsy""; ""Contents""; ""Foreword""; ""Bromides""; ""Adrenocorticotropic hormone and corticosteroids""; ""Stiripentol""; ""Felbamate""; ""Rufinamide"" |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Over half of epilepsies start before the age of 20 years and nearly 25% of them are refractory. A tiny proportion of them are even labelled a rare illness (ie: one affecting less than 200,000 people in the United States or less than 5 out of 10,000 people in the European Union). For these patients, two problems in their management arise: In children, seizures affect an immature brain and can impact its development. It is therefore essential to treat them so that brain development continues as normally as possible. The rarity of these syndromes does not encourage the pharmaceutical industry to invest in research. Therefore, there are few drugs available. However, a few target syndromes with a particularly unfavourable diagnosis. This work outlines 6 molecules in detail that are specifically used in epileptic encephalopathies. Every aspect of these molecules is discussed, including drug development, indication, efficacy, cost, etc. Drafted by international experts in the field of epileptology, it provides all the necessary information on orphan drugs and their clinical use. |
|
|
|
|
|
|
|
| |